These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 30023003)
1. Adding ezetimibe to statin therapy: latest evidence and clinical implications. Vavlukis M; Vavlukis A Drugs Context; 2018; 7():212534. PubMed ID: 30023003 [TBL] [Abstract][Full Text] [Related]
2. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors. Choi JY; Na JO J Lipid Atheroscler; 2019 Sep; 8(2):183-191. PubMed ID: 32821708 [TBL] [Abstract][Full Text] [Related]
4. Role of colesevelam in combination lipid-lowering therapy. Jones MR; Nwose OM Am J Cardiovasc Drugs; 2013 Oct; 13(5):315-23. PubMed ID: 23913404 [TBL] [Abstract][Full Text] [Related]
5. Role of Different Low-Density Lipoprotein-Lowering Medications on Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients With Diabetes Mellitus. Saag JL; Gross D; Stirt D; Espina Rey A; Gros B Cureus; 2023 Jun; 15(6):e40905. PubMed ID: 37492827 [TBL] [Abstract][Full Text] [Related]
7. Safety and Effectiveness of High-Intensity Statins Versus Low/Moderate-Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL-C Goals: A Systematic Review and Meta-Analysis. Soleimani H; Mousavi A; Shojaei S; Tavakoli K; Salabat D; Farahani Rad F; Askari MK; Nelson J; Ruzieh M; Hosseini K Clin Cardiol; 2024 Aug; 47(8):e24334. PubMed ID: 39135464 [TBL] [Abstract][Full Text] [Related]
8. Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses. Shaya FT; Sing K; Milam R; Husain F; Del Aguila MA; Patel MY Am J Cardiovasc Drugs; 2020 Jun; 20(3):239-248. PubMed ID: 31724105 [TBL] [Abstract][Full Text] [Related]
9. Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial. Lee SJ; Cha JJ; Choi WG; Lee WS; Jeong JO; Choi S; Cho YH; Park W; Yoon CH; Lee YJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Hong SJ; Kim JS; JAMA Cardiol; 2023 Sep; 8(9):853-858. PubMed ID: 37531130 [TBL] [Abstract][Full Text] [Related]
10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
11. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease. Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202 [TBL] [Abstract][Full Text] [Related]
12. Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation. Ara R; Tumur I; Pandor A; Duenas A; Williams R; Wilkinson A; Paisley S; Chilcott J Health Technol Assess; 2008 May; 12(21):iii, xi-xiii, 1-212. PubMed ID: 18485273 [TBL] [Abstract][Full Text] [Related]
14. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
15. Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations. Adhyaru BB; Jacobson TA Curr Atheroscler Rep; 2017 Jun; 19(6):29. PubMed ID: 28500517 [TBL] [Abstract][Full Text] [Related]
16. 2017 Taiwan lipid guidelines for high risk patients. Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI; J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature. Yu M; Liang C; Kong Q; Wang Y; Li M Lipids Health Dis; 2020 Jan; 19(1):1. PubMed ID: 31900179 [TBL] [Abstract][Full Text] [Related]
19. Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial. Lv X; Liu X; Peng Y; Li W; Wang J; Chen X; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L J Stroke Cerebrovasc Dis; 2024 May; 33(5):107647. PubMed ID: 38431112 [TBL] [Abstract][Full Text] [Related]